Pharmsil RP18 is a silica-based HPLC column with a pharmaceutical-grade octadecyl bonded phase, designed to deliver strong hydrophobic retention, reproducibility, and robustness for routine pharmaceutical applications. With its optimized bonding chemistry, it ensures sharp peak shapes and consistent performance for a wide range of analytes.
The Pharmsil RP18 column is particularly suitable for quality control, impurity profiling, and regulatory compliance testing, where accuracy and reproducibility are essential. Its robust design ensures long column lifetimes and reliable results under routine and demanding chromatographic conditions.
Pharmsil RP18 combines strong hydrophobic retention with pharmaceutical-grade robustness – the dependable choice for laboratories performing routine and regulatory HPLC separations.
Silica-based stationary phase with pharmaceutical-grade C18 bonded chemistry
Strong hydrophobic retention for a wide range of analytes
Excellent reproducibility and robustness for routine testing
Optimized for pharmaceutical quality control and regulatory analysis
Available particle sizes: 3 µm, 5 µm
Pharmaceutical impurity profiling and stability testing
Quality control and regulatory compliance analysis
Biochemical testing of hydrophobic drugs and metabolites
Method development requiring robust and reproducible C18 selectivity
| Particle Sizes |
|
|---|---|
| Pore Size | 120 Å |
| Surface Area | 300 m²/g |
| Phase/Modification | C18 |
| Particle Type | |
| Separation Mode | |
| USP Code | |
| Endcapping | Yes |
| Carbonload | 17 % |
| pH Range | 2 to 8 |
| Phase | Material Number |
|---|---|
| Pharmsil RP18, 3 µm | DSOD10310. |
| Pharmsil RP18, 5 µm | DSOD10510. |